To provide innovative diagnostics and therapies to improve the lives of many.
Karim Brandt, Ph.D
Chief Executive Officer
Karim was awarded his PhD in Biochemistry and Immunology by the University of Geneva, where he spent more than 10 years in basic research. He is former Group Leader within the Cardiology Department of the University and holds several patents related to his research. In 2017, he co-founded Endotelix. Karim is an immunology, IP and innovation expert.
Chief Operating Officer
Marc graduated from the University of Dundee in 2005 with a degree in Anatomical Sciences and Biochemistry. He spent the following five years working at the University as an Anatomist and part-time lecturer. He then occupied multiple positions as program leader at Ross University School of Medicine before joining a Swiss Biotech/Biopharma company in 2015. In 2017 he co-founded Endotelix. Marc is responsible for communications, sales and marketing development.